
498
Downloads
44
Episodes
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Episodes
Sunday Jan 18, 2026
E12 - Endometrial Cancer Classification
Sunday Jan 18, 2026
Sunday Jan 18, 2026
E12 | 10 min | Latest | Publication Link
- Podcast based on: Restaino, S.; Pellecchia, G.; Arcieri, M.; Mariuzzi, L.; Orsaria, M.; Tulisso, A.; Cesselli, D.; Bulfoni, M.; Poli, A.; Paparcura, F.; Bogani, G.; Mariani, A.; Zannoni, G.; Scambia, G.; Vizzielli, G. Alignment of Molecular Classification Between Diagnosis and Recurrence in Endometrial Cancer: Lessons from a Single-Institution Experience to Inform Future Pathways. Cancers 2026, 18, 247. https://doi.org/10.3390/cancers18020247
Type: Article | Publication date: 13 January 2026 - Summary: Endometrial cancer treatment and prognosis have greatly improved thanks to advances in understanding its molecular profile. However, it is still unclear whether these molecular characteristics remain stable over time, particularly when the disease returns after initial treatment. This study explores the concordance and potential evolution of molecular classification between primary diagnosis and recurrence in endometrial cancer, building upon emerging evidence that has begun to address this question. This study explores the concordance and potential evolution of molecular classification between primary diagnosis and recurrence in endometrial cancer, building upon emerging evidence that has begun to address this question. By examining this relationship, our research provides valuable preliminary data that could guide future studies on the biological behavior of recurrent disease. These insights may ultimately contribute to more precise and personalized treatment strategies for patients with endometrial cancer.
- Keywords: molecular biology; endometrial cancer; recurrence
Disclaimer:
This podcast provides a synthetically generated voice summary and discussion of scientific publications. The views expressed do not represent the views of the original authors, journals, or publishers. This podcast uses AI-assisted summaries, so it may or may not introduce inaccuracies or omit important details. Listeners are strongly encouraged to consult the original publications or sources for full context and accuracy. This podcast is for educational and informational purposes only and does not constitute clinical advice, medical guidance, or recommendations. The creators of this podcast are not liable for any errors, omissions, or outcomes resulting from the use of the information provided.

No comments yet. Be the first to say something!